Natural Product (NP) Details

General Information of the NP (ID: NP9718)
Name
Methylselenocysteine
Synonyms
Se-methylselenocysteine; 26046-90-2; Methylselenocysteine; 3-(Methylseleno)-L-alanine; (R)-2-Amino-3-(methylselanyl)propanoic acid; Se-Methyl-L-selenocysteine; L-Alanine, 3-(methylseleno)-; Selenium-methylselenocystine; Se-Methyl-seleno-L-cysteine; UNII-TWK220499Z; CHEBI:27812; TWK220499Z; Se-methylseleno-L-cysteine; Se-(Methyl)selenocysteine hydrochloride; (2R)-2-amino-3-methylselanylpropanoic acid; Se-methylseleno-L-cysteine, 98%; Selenomethylselenocysteine; CCRIS 5465; Selenomethyl selenocysteine; Methylseleno-L-cysteine; L-Se-methylselenocysteine; C4H9NO2Se; L-methylselenocysteine; methyl-L-selenocysteine; Cysteine, seleno-methyl-; Lopac0_000799; 3-(Methylselanyl)-L-alanine; CHEMBL62382; SCHEMBL420015; Se-(Methyl)seleno-L-cysteine; L-Selenomethylcysteine 0.5% Tr; 2218AB; ANW-64816; MFCD00800565; AKOS016005152; 2-Amino-3-methylselenyl propionic acid; CCG-204883; DB12697; SDCCGSBI-0050776.P002; NCGC00162258-01; NCGC00162258-02; HY-114245; CS-0080570; (2R)-2-amino-3-(methylselanyl)propanoic acid; C05689; 046S902; J-016235; Q21099600; 06E70014-448A-45CD-9AF1-4C0B9CF51C14
    Click to Show/Hide
Species Origin Astragalus bisulcatus ...     Click to Show/Hide
Astragalus bisulcatus
Kingdom: Viridiplantae
Phylum: Streptophyta
Class: Magnoliopsida
Order: Fabales
Family: Fabaceae
Genus: Astragalus
Species: Astragalus bisulcatus
Disease Breast cancer [ICD-11: 2C60] Clinical Trial [1]
Structure
Click to Download Mol
2D MOL

3D MOL

    Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product
Formula
C4H9NO2Se
PubChem CID
147004
Canonical SMILES
C[Se]CC(C(=O)O)N
InChI
1S/C4H9NO2Se/c1-8-2-3(5)4(6)7/h3H,2,5H2,1H3,(H,6,7)/t3-/m0/s1
InChIKey
XDSSPSLGNGIIHP-VKHMYHEASA-N
CAS Number
CAS 26046-90-2
ChEBI ID
CHEBI:27812
Herb ID
HBIN035417
SymMap ID
SMIT07155
TCMSP ID
MOL005383
TTD Drug ID
D53CMU
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally
    α. A List of Drug(s) Whose Efficacy can be Enhanced by This NP
          Tamoxifen      Breast cancer     Click to Show/Hide the Molecular Data of This Drug
                 Achieving Therapeutic Synergy     Click to Show/Hide
                    Representative Experiment Reporting the Effect of This Combination [2]
                    Detail(s)  Combination Info  click to show the detail info of this combination
                    Molecule(s)
                    Regulation		 Down-regulation Expression CCND1  Molecule Info 
Pathway MAP
                    In-vitro Model MCF-7 CVCL_0031 Invasive breast carcinoma Homo sapiens
                    In-vivo Model About 5*106 cells suspension in 50 uL sterile PBS were mixed with 100 uL Matrigel and administered within both sides of the inguinal mammary fat pad of NU/NU immune-compromised female ovariectomized mice.
                    Experimental
                    Result(s)		 These findings demonstrate synergistic growth inhibition of ERalpha positive breast cancer xenografts by combination of tamoxifen with organic selenium compounds.
References
Reference 1 ClinicalTrials.gov (NCT01611038) Methylselenocysteine Effects on Circadian Rhythm. U.S. National Institutes of Health.
Reference 2 Combination of methylselenocysteine with tamoxifen inhibits MCF-7 breast cancer xenografts in nude mice through elevated apoptosis and reduced angiogenesis. Breast Cancer Res Treat. 2009 Nov;118(1):33-43.
 Download Picture         KEGG Link